← Open Payments lookup

CHRISTOPHER BELL: Open Payments

NPI 1225190382 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$119,731 in 214 payments from 14 companies in 2025. Trend: 2023 $78,515 · 2024 $103,090 · 2025 $119,731

Speaker / faculty: $81,916Travel & lodging: $19,248Consulting: $14,077Food & beverage: $4,490
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP57$45,673
Alnylam Pharmaceuticals Inc.64$36,474
BridgeBio Pharma, Inc.38$12,294
E.R. Squibb & Sons, L.L.C.22$12,249
Novo Nordisk Inc4$7,166
CVRx, Inc.7$4,233
Boehringer Ingelheim Pharmaceuticals, Inc.4$994
Abbott Laboratories3$286
Boston Scientific Corporation4$203
Lexicon Pharmaceuticals, Inc.1$55

Products named: WAINUA, AMVUTTRA, Attruby, CAMZYOS, Ozempic, Barostim Neo System, FREESTYLE LIBRE PRO, General - Therapies.

Industry payments across MS — which companies pay providers there.